RT Journal Article
SR Electronic
T1 743 INCLINE-101: preliminary safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TAC-001 (TLR9 agonist conjugated to a CD22 mAb) in patients with advanced or metastatic solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A838
OP A838
DO 10.1136/jitc-2023-SITC2023.0743
VO 11
IS Suppl 1
A1 Perez, Cesar
A1 Henry, Jason
A1 Kim, Sunnie
A1 El-Khoueiry, Anthony
A1 Gutierrez, Martin
A1 Pavlick, Anna
A1 Lee, Joshua
A1 Bollini, Sangeetha
A1 Jin, Feng
A1 Harrabi, Ons
A1 Heller, Kevin N
A1 Humphries, Timothy
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A838.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.